Atea Pharmaceuticals
AVIR
AVIR
142 hedge funds and large institutions have $477M invested in Atea Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
142
Holders Change
+1
Holders Change %
+0.71%
% of All Funds
2.19%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
48
Increased
46
Reduced
35
Closed
47
Calls
$15.8M
Puts
$14.2M
Net Calls
+$1.56M
Net Calls Change
+$326K
Top Buyers
1 |
EC
1
EcoR1 Capital
San Francisco,
California
|
$48.1M |
2 |
2
BlackRock
New York
|
$51.7M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$14.9M |
4 |
4
Schroder Investment Management Group
London,
United Kingdom
|
$13.8M |
5 |
5
State Street
Boston,
Massachusetts
|
$20.8M |